photo credit: https://www.linkedin.com/in/arthur-mikaelian-18693218/

Key Takeaways

• Many compounds fail due to breakdown or poor absorption, not chemical flaws.
• Enhancement improves performance without altering the original molecular structure.
• Nanoparticles, liposomes, and depot systems extend circulation and improve targeting.
• Enhancement reduces development risk by building on validated compounds and known safety data.
• Delivery-route optimization helps a single compound succeed across multiple therapeutic formats.